PetMed Express Announces Director Departure, Officer Compensation

Ticker: PETS · Form: 8-K · Filed: 2025-08-12T00:00:00.000Z

Sentiment: neutral

Topics: director-departure, officer-compensation, corporate-governance

Related Tickers: PETS

TL;DR

PETS director Zalesin out, exec comp details, and financials filed.

AI Summary

PetMed Express, Inc. announced on August 11, 2025, the departure of Director Steven R. Zalesin. The company also reported on compensatory arrangements for certain officers and provided a Regulation FD disclosure. Additionally, the filing includes financial statements and exhibits.

Why It Matters

Changes in directorship and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence.

Risk Assessment

Risk Level: low — The filing primarily concerns routine corporate governance and disclosures, with no immediate financial distress or significant operational changes indicated.

Key Players & Entities

FAQ

Who is Steven R. Zalesin and what was his role at PetMed Express?

Steven R. Zalesin was a Director at PetMed Express, Inc., and his departure was reported on August 11, 2025.

What specific items are covered in this 8-K filing?

This 8-K filing covers the departure of directors or certain officers, election of directors, appointment of certain officers, compensatory arrangements of certain officers, Regulation FD disclosures, other events, and financial statements and exhibits.

When was the earliest event reported in this filing?

The earliest event reported in this filing occurred on August 11, 2025.

What is the principal executive office address for PetMed Express, Inc.?

The principal executive offices of PetMed Express, Inc. are located at 420 South Congress Avenue, Delray Beach, Florida 33445.

What is the telephone number for PetMed Express, Inc.?

The telephone number for PetMed Express, Inc. is (561) 526-4444.

From the Filing

0001040130-25-000049.txt : 20250812 0001040130-25-000049.hdr.sgml : 20250812 20250812162055 ACCESSION NUMBER: 0001040130-25-000049 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20250811 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250812 DATE AS OF CHANGE: 20250812 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PETMED EXPRESS INC CENTRAL INDEX KEY: 0001040130 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] ORGANIZATION NAME: 07 Trade & Services EIN: 650680967 STATE OF INCORPORATION: FL FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-42429 FILM NUMBER: 251207040 BUSINESS ADDRESS: STREET 1: 420 SOUTH CONGRESS AVENUE CITY: DELRAY BEACH STATE: FL ZIP: 33445 BUSINESS PHONE: (561) 426-4444 MAIL ADDRESS: STREET 1: 420 SOUTH CONGRESS AVENUE CITY: DELRAY BEACH STATE: FL ZIP: 33445 8-K 1 pets-20250811.htm 8-K pets-20250811 0001040130 FALSE 0001040130 2025-08-11 2025-08-11 0001040130 us-gaap:CommonStockMember 2025-08-11 2025-08-11 0001040130 us-gaap:PreferredStockMember 2025-08-11 2025-08-11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM  8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported):  August 11, 2025 PetMed Express, Inc. (Exact name of registrant as specified in its charter) Florida 000-28827 65-0680967 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 420 South Congress Avenue , Delray Beach , Florida 33445 (Address of principal executive offices) (Zip Code) ( 561 )  526-4444 (Registrant’s telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $.001 per share PETS NASDAQ Preferred Stock Purchase Rights N/A NASDAQ Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company  o If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Resignation of Sandra Campos On August 11, 2025, following a meeting of the Board of Directors (the “Board”) of PetMed Express, Inc. (the “Company”), the Company and Sandra Campos entered into a Separation Agreement pursuant to which Ms. Campos resigned as the Chief Executive Officer (Principal Executive Officer) and President of the Company, effe

View on Read The Filing